Canadian approval for Neuromedical Systems:
This article was originally published in Clinica
Executive Summary
US company Neuromedical Systems has received clearance in Canada to market its Papnet cervical cancer testing system for primary screening. The system is already used in Europe and Asia as a primary screener and a US multicentre clinical trial has begun.